Clinical Trials Sponsored by Sahel Taravati, M.D.
Total 1 results
-
Sahel Taravati, M.D.CompletedHemiplegia and/or Hemiparesis Following StrokeTurkey
Sponsors and Collaborators
- Oblikue Consulting
- The Third Hospital of HanDan
- The Finnish Hearth Association
- Prof. OTTO Beisheim Stiftung (Germany)
- Beijing Municipal Education Commission
- ICE Intelligent Healthcare Co., Ltd
- Livivos, Inc.
- Semyung University Affiliated Oriental Medical Hospital
- Ayse Cal
- Andre Tsin Chih Chen
- Health Pharma Professional Research
- Antonio Martín Duce
- Semler Scientific
- CP-foreningen
- PETROSYAN Andreanik
- Hyben Vital ApS
- Notitia Biotechnologies Company
- Neijiang Center for Disease Control and Prevention
- Riverview Health Centre Foundation
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- View Full List
Medical Conditions
- Refractory Oropharyngeal Squamous Cell Carcinoma
- Visual Field Defect Homonymous Bilateral
- Systemic Nickel Allergic Syndrome
- The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase
- Medication Induced Acute Pancreatitis
- Chronic Heart Disease
- Under-eyes Dark Circles
- Weight Loss Trajectory
- Male Patients
- Adult T Lymphoblastic Lymphoma
- Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
- Sprain of Sacroiliac Ligament
- GI Bleed
- Acute T Lymphoblastic Leukemia (T-ALL)
- Invasive Group A Streptococcal Disease
- Muscle Stretching Exercise; Postural Balance; Stabilometry; Platform
- Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- TGF-β
- Non-Melanomatous Skin Cancer
- Peritoneal Dialysis-related Infection
- View Full List
Drug Interventions
- Naproxen
- Triamcinolone
- Durvalumab and Tremelimumab
- Vaway
- Venetoclax
- Fluoxetine
- MEDI4736
- Aclidinium bromide
- Irinotecan
- Glimepiride
- Ketorolac
- Quarfloxin
- Lisinopril and Hydrochlorothiazide Tablets (20+25) mg
- Empagliflozin 25 mg
- Anlotinib
- Crushed d-amphetamine sulfate IR tablets
- Low Intensity Counseling + bupropion + PRN NRT
- DTG/3TC
- AL-53817 Ophthalmic Solution, 0.1%
- Anti-Rejection Agents
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Belgium
- Contract Research Organizations in Burundi
- Contract Research Organizations in Congo
- Contract Research Organizations in Croatia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Moldova
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Norway
- Contract Research Organizations in Uganda
- Contract Research Organizations in Zimbabwe
- CRO list by country